Woman who lost 23 kg in 5 months shares 5 things she gave up to reach her fitness goals: ‘I stuck to home food’ | Health – Hindustan Times  Hindustan Times
source

INDIANAPOLIS — Want to go to Game 6 of the NBA Finals?
IU Health Foundation is holding a sweepstakes for two tickets to Game 6 on Thursday, June 19 at 8:30 p.m. in Indianapolis. The Indiana Pacers will face off against the Oklahoma City Thunder. 
You can enter the sweepstakes by making a $100 contribution to IU Health Foundation. A $100 contribution is one entry in the sweepstakes. Every additional $100 you contribute is another entry into the sweepstakes.
The sweepstakes will be open from Saturday, June 14 at 8 a.m. through Tuesday, June 17 at 8 p.m.
Winners will be notified on Wednesday, June 18, officials said.
You can enter for a chance to win on IU Health Foundation’s website. 
To stream 13 WTHR on your phone, you need the 13 WTHR app.
Next up in 5
Example video title will go here for this video
Next up in 5
Example video title will go here for this video

In Other News

source

Air pollution causes around 50,000 deaths each year in the U.S. Yet, not all pollutants are equally harmful. Among the most dangerous are fine airborne particles.
Historically, research has focused on PM 2.5, particles smaller than 2.5 microns. Now, scientists have turned to an even finer pollutant: PM 1. These particles, less than one micron wide, are small enough to infiltrate deep into human lungs.
A recent study by a team at Washington University in St. Louis offers the first high-resolution, 25-year dataset of PM 1 levels across the contiguous United States.
“This measurement serves as a starting point to understand which pollutants regulators could target to make the most effective health impact,” said study co-author Dr. Randall Martin.
Unlike PM 2.5, which includes larger particles like dust, PM 1 is mostly made up of combustion products: black carbon, sulphates, and organic matter.
These smaller particles reach the alveolar regions of the lungs and cause more damage per unit mass. PM 1 can come from diesel exhaust, wildfires, and also industrial emissions.
Because the pollutant bypasses the body’s defenses more easily, its impact may be more severe. These particles are about six times smaller than red blood cells. Their size allows them to travel deep into lung tissues and even the bloodstream.
Thanks to environmental regulations, average PM 1 levels have dropped. From 1998 to 2022, the U.S. saw a significant decline in PM 1 levels at about 0.23 µg/m³ per year. This accounted for 86 percent of the total PM 2.5 reduction.
But since 2010, this progress has slowed due to wildfires, especially in the western states. Areas like Los Angeles and Phoenix now show higher uncertainties in PM 1 estimates because wildfires boost organic matter concentrations.
According the study, some western regions see annual PM 1 uncertainty levels exceeding 30 percent, mainly due to wildfire smoke.
The study shows that PM 1 levels remain highest in the eastern U.S. and in major cities. PM 1 sources are mostly human-made, making it easier to manage compared to natural dust.
Urban populations, especially Black and Asian communities, have seen the greatest improvements due to reduced combustion emissions.
But not all communities benefit equally. Native American communities, often living in the arid west, saw smaller reductions. Wildfires and natural dust contribute more heavily to their exposure, and these are harder to control.
This study used satellite data, chemical models, and ground stations to estimate particle levels across over eight million land pixels. The data aligns well with physical ground measurements from devices like MOUDI and TEOM.
According to the analysis, 83 percent of the U.S. population lived in areas with PM 1 uncertainty under 10 percent. “Putting the seven species together, we can calculate the total PM 1 concentration over the country,” said Dr. Chi Li, lead author of the study.
In 2022, the major components of PM 1 included organic matter, which made up 47 percent of the total, followed by sulphate at 22 percent, nitrate at 12 percent, black carbon at eight percent, and ammonium at seven percent.
In contrast, dust and sea salt, which are more prominent in PM 2.5, contributed less than five percent to PM 1.
“When EPA first promulgated a fine PM air quality standard in 1997, there was considerable discussion about regulating PM 1 or PM 2.5,” said study co-author Professor Jay Turner.
“For numerous reasons, including but not limited to the lack of health impacts studies for PM 1 compared to studies for PM 2.5, the latter was chosen.”
That may change. PM 1 is more closely tied to urban combustion, which makes it easier to regulate. Unlike mineral dust, these emissions can be managed through policy. The study strongly recommends integrating PM 1 into monitoring systems and health impact studies.
“This dataset offers unprecedented information for the United States about an important pollutant for which few other measurements exist,” said Dr. Martin.
As air pollution continues to change due to shifting environmental conditions and human activities, it becomes increasingly important to pay closer attention to these specific particles.
Although they are extremely small, they pose serious risks to human health and can penetrate deep into the body. For a long time, these harmful particles have not received enough attention in air quality regulations, making them a hidden danger in many communities.
However, researchers now have access to better tools, advanced monitoring technologies, and long-term data that make it possible to track and understand their impact more clearly.
With this new information, there is a real opportunity to create stronger protections and shape policies that respond more accurately to the health risks posed by particle pollution.
With continued efforts, PM 1 could become the next target for environmental health policy in the U.S. – a shift that might save thousands of lives each year.
The study is published in the journal The Lancet Planetary Health.
—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–

source

June 14, 2025 08:48 ET  | Source: Bleichmar Fonti & Auld Bleichmar Fonti & Auld
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Investors have until July 11, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Elevance common stock.   The case is pending in the U.S. District Court for the Southern District of Indiana and is captioned Miller v. Elevance Health, Inc., et al., No. 25-cv-0092.
Why was Elevance Sued for Securities Fraud?
Elevance provides health insurance plans. This includes contracting with states to administer Medicaid benefits. States routinely review Medicaid eligibility, but during COVID, the federal government paused this process. The pause ended in 2023, and states resumed redetermining Medicaid eligibility.
During the relevant period, Elevance represented that it was closely monitoring the cost trends associated with the redetermination process and that the rates Elevance was negotiating were sufficient to address the risk profiles of those patients staying on Medicaid.
As alleged, in truth, the redeterminations caused a significant increase in the acuity and utilization of Elevance’s Medicaid members. What’s more, the shift occurred to a degree that was not reflected in Elevance’s rate negotiations or in its financial guidance for 2024.
The Stock Declines as the Truth is Revealed
On July 17, 2024, Elevance stated that it was now “expecting second-half utilization to increase in Medicaid” and that it was “seeing signs of increased utilization across the broader Medicaid population.” On this news, the price of Elevance stock declined $32.21 per share, or nearly 6%, from $553.14 per share on July 16, 2024, to $520.93 per share on July 17, 2024.
Then, on October 17, 2024, Elevance announced its Q3 2024 financial results, revealing that its missed consensus earnings per share (“EPS”) expectations by $1.33, or 13.7%, “due to elevated medical costs in [its] Medicaid business.” On this news, the price of Elevance stock declined $52.61 per share, or nearly 11%, from $496.96 per share on October 16, 2024, to $444.35 per share on October 17, 2024.
Click here if you suffered losses: https://www.bfalaw.com/cases-investigations/elevance-health-inc.
What Can You Do?
If you invested in Elevance you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases-investigations/elevance-health-inc
Or contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases-investigations/elevance-health-inc
Attorney advertising. Past results do not guarantee future outcomes.
Compass Diversified Holdings investors that lost money are notified to contact BFA Law before July 8, 2025 securities fraud class action deadline.
Civitas Resources, Inc. investors that lost money are notified to contact BFA Law before July 1, 2025 securities fraud class action deadline.

source

Your breath is one of a kind. A study published June 12 in the Cell Press journal Current Biology demonstrated that scientists can identify individuals based solely on their breathing patterns with 96.8% accuracy. These nasal respiratory “fingerprints” also offer insights into physical and mental health.
The research stemmed from the lab’s interest in olfaction, or the sense of smell. In mammals, the brain processes odor information during inhalation. This link between the brain and breathing led researchers to wonder: since every brain is unique, wouldn’t each person’s breathing pattern reflect that?
To test the idea, the team developed a lightweight wearable device that tracks nasal airflow continuously for 24 hours using soft tubes placed under the nostrils. Most breathing tests last just one to 20 minutes, focusing on evaluating lung function or diagnosing disease. But those brief snapshots aren’t enough to capture subtle patterns.
“You would think that breathing has been measured and analyzed in every way,” says author Noam Sobel of the Weizmann Institute of Science, Israel. “Yet we stumbled upon a completely new way to look at respiration. We consider this as a brain readout.”
Sobel’s team fitted 100 healthy young adults with the device and asked them to go about their daily lives. Using the collected data, the team identified individuals using only their breathing patterns with high accuracy. This high-level accuracy remained consistent across multiple retests conducted over a two-year period, rivaling the precision of some voice recognition technologies.
“I thought it would be really hard to identify someone because everyone is doing different things, like running, studying, or resting,” says author Timna Soroka of the Weizmann Institute of Science. “But it turns out their breathing patterns were remarkably distinct.”
Moreover, the study found that these respiratory fingerprints correlated with a person’s body mass index, sleep-wake cycle, levels of depression and anxiety, and even behavioral traits. For example, participants who scored relatively higher on anxiety questionnaires had shorter inhales and more variability in the pauses between breaths during sleep. Soroka noted that none of the participants met clinical diagnostic criteria for mental or behavioral conditions. The results suggest that long-term nasal airflow monitoring may serve as a window into physical and emotional well-being.
“We intuitively assume that how depressed or anxious you are changes the way you breathe,” says Sobel. “But it might be the other way around. Perhaps the way you breathe makes you anxious or depressed. If that’s true, we might be able to change the way you breathe to change those conditions.”
The current device still faces real-world challenges. A tube that runs under the nose is often associated with illness and may deter adoption. The device also doesn’t account for mouth breathing and can slip out of place when sleeping. The team aims to design a more discreet and comfortable version for everyday use.
Soroka and Sobel are already investigating whether people can mimic healthy breathing patterns to improve their mental and emotional states. “We definitely want to go beyond diagnostics to treatment, and we are cautiously optimistic,” says Sobel.
Story Source:
Materials provided by Cell Press. Note: Content may be edited for style and length.
Journal Reference:
Cite This Page:
Stay informed with ScienceDaily’s free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:
Keep up to date with the latest news from ScienceDaily via social networks:
Tell us what you think of ScienceDaily — we welcome both positive and negative comments. Have any problems using the site? Questions?

source

A Woman’s Journey: Surprising Tips to Reduce Heart Disease  Johns Hopkins Medicine
source